Which Is a Better Investment, Neogen Corporation or Stevanato Group SpA Stock?

By AAII Staff
September 02, 2026
Large versus logo comparing two stocks in the same industry
Featured Tickers:

Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Neogen Corporation or Stevanato Group S.p.A. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Neogen Corporation and Stevanato Group S.p.A. compare based on key financial metrics to determine which better meets your investment needs.

About Neogen Corporation and Stevanato Group S.p.A.

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Latest Health Care Equipment & Supplies and Neogen Corporation, Stevanato Group S.p.A. Stock News

As of September 1, 2026, Neogen Corporation had a $2.5 billion market capitalization, compared to the Health Care Equipment & Supplies median of $405.9 million. Neogen Corporation’s stock is up 66.5% in 2026, down 0.5% in the previous five trading days and up 102.44% in the past year.

Currently, Neogen Corporation does not have a price-earnings ratio. Neogen Corporation’s trailing 12-month revenue is $870.4 million with a -0.9% net profit margin. Year-over-year quarterly sales growth most recently was -0.1%. Analysts expect adjusted earnings to reach $0.310 per share for the current fiscal year. Neogen Corporation does not currently pay a dividend.

As of September 1, 2026, Stevanato Group S.p.A. had a $5.7 billion market cap, putting it in the 69th percentile of all stocks. Stevanato Group S.p.A.’s stock is up 2.9% in 2026, down 7.5% in the previous five trading days and down 10% in the past year.

Currently, Stevanato Group S.p.A.’s price-earnings ratio is 37.0. Stevanato Group S.p.A.’s trailing 12-month revenue is $1.4 billion with a 11.0% net profit margin. Year-over-year quarterly sales growth most recently was 4.9%. Analysts expect adjusted earnings to reach $0.704 per share for the current fiscal year. Stevanato Group S.p.A. currently has a 0.3% dividend yield.

How We Compare Neogen Corporation and Stevanato Group S.p.A. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Neogen Corporation and Stevanato Group S.p.A.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Neogen Corporation and Stevanato Group S.p.A. Stock Value Grades

Company Ticker Value
Neogen Corporation NEOG D
Stevanato Group S.p.A. STVN D

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Neogen Corporation has a Value Score of 25, which is Expensive. Stevanato Group S.p.A. has a Value Score of 25, which is Expensive.

The Value Stock Winner: No Clear Winner

Neither Neogen Corporation or Stevanato Group S.p.A. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Neogen Corporation or Stevanato Group S.p.A. is the better investment when it comes to value.

Neogen Corporation and Stevanato Group S.p.A. Growth Grades

Company Ticker Growth
Neogen Corporation NEOG B
Stevanato Group S.p.A. STVN A

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Neogen Corporation has a Growth Score of 64, which is Strong. Stevanato Group S.p.A. has a Growth Score of 82, which is Very Strong.

The Growth Grade Winner: Stevanato Group S.p.A.

As you can clearly see from the Growth Grade breakdown above, Stevanato Group S.p.A. has a more attractive growth grade than Neogen Corporation. For investors who focus solely on how a company is growing relative to other companies in the same industry, Stevanato Group S.p.A. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Neogen Corporation and Stevanato Group S.p.A.’s Momentum Grades

Company Ticker Momentum
Neogen Corporation NEOG A
Stevanato Group S.p.A. STVN C

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Neogen Corporation has a Momentum Score of 94, which is Very Strong. Stevanato Group S.p.A. has a Momentum Score of 43, which is Average.

The Momentum Grade Winner: Neogen Corporation

As you can clearly see from the Momentum Grade breakdown above, Neogen Corporation is considered to have stronger momentum compared to Stevanato Group S.p.A.. For those specifically looking for companies that have stronger momentum compared to other companies in the same industry, Neogen Corporation could be a good stock to invest in. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Don’t Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions

Other Neogen Corporation and Stevanato Group S.p.A. Grades

In addition to Growth, Momentum and Value, A+ Investor also provides grades for Estimate Revisions and Quality.

AAII Platinum Banner

Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Neogen Corporation and Stevanato Group S.p.A. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Neogen Corporation or Stevanato Group S.p.A. Stock?

Overall, Neogen Corporation stock has a Value Score of 25, Growth Score of 64 and Momentum Score of 94.

Stevanato Group S.p.A. stock has a Value Score of 25, Growth Score of 82 and Momentum Score of 43.

Comparing Neogen Corporation and Stevanato Group S.p.A.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

Learn More About A+ Investor

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.



Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.